Associated Papers
The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms.
Ferng TT et al.
Molecular Cancer Therapeutics, 2022
Modulation of FLT3 signal transduction through cytoplasmic cysteine residues indicates the potential for redox regulation.
Böhmer A et al.
Redox Biology, 2020
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations.
Yamaura T et al.
Blood, 2018
Select a paper to view details